Tag Archives: social media

Social Media Raise Concerns for Marketers, Trial Sponsors

While biopharmaceutical companies are using websites and third-party postings to provide information on medical products — despite a host of regulatory issues — social media use is in its infancy related to the design and conduct of clinical trials. A recent report from the Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) finds that […]
Posted in FDA, Regulatory, social media | Also tagged , , , , | Leave a comment

FDA Guidances, OIG Investigations to Shape Drug Marketing, Research

Marketers may see further advice from the Food and Drug Administration in the coming year that clarifies how they can use social media. Priority topics:  presenting risk and benefit information in limited space; correcting independent/third party misinformation about a drug or medical device; and appropriate use of links, according to the agenda for the Center […]
Posted in Advertising, Biotech, E-Media, FDA, Legal, pricing, Regulatory, social media | Also tagged , , , , , , | Leave a comment

On-Demand Marketing Re-invents Customer Relationships

Staying on top of the marketing information stream can be difficult for your customers, but plans for a ‘holistic’ healthcare network could make relationships easier to manage. 2014 has started the way 2013 ended in the long and painful saga of pharma and Social media. In a January 21st post for Forbes, Ed Silverman reported […]
Posted in E-Media, Marketing, multimedia, social media | Also tagged , , , | 1 Comment

FDA Rolls Out Social Media Guidance — Slowly

Pharma marketers have been clamoring for clear advice from the Food and Drug Administration on how to accommodate established rules governing drug promotion to today’s world of internet communications and social messaging. Now, a guidance from the agency’s Office of Prescription Drug Promotion (OPDP) —and its counterparts for biologics and animal drugs — outlines agency […]
Posted in multimedia, Regulatory, social media | Also tagged , | Leave a comment

Five Ways for Pharma to Read Between the Tweets

Sharon Karlsberg, Principal, ZS Associates (Sponsored Content) While buzz on Twitter will never outweigh critical data in a peer-reviewed publication, social media is becoming an important part of our industry’s dialogue. The oncology market is no exception, as insight gleaned from recent Twitter traffic and trends reveals.
Posted in Strategy | Also tagged | 1 Comment
  • Categories

  • Meta